At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MTCR Metacrine, Inc.
Market Closed 06-20 16:00:00 EDT Delay
Metacrine - Filed Certificate Of Dissolution With Secretary Of State Of State Of Delaware To Effect Complete Liquidation And Dissolution Of Company
T-Reuters  ·  2023-03-25
Metacrine - Filed Certificate Of Dissolution With Secretary Of State Of State Of Delaware To Effect Complete Liquidation And Dissolution Of Company
BRIEF-Metacrine Inc Common Stock Will Be Delisted From Nasdaq
Reuters  ·  2023-03-04
BRIEF-Metacrine Inc Common Stock Will Be Delisted From Nasdaq
Nasdaq to delist shares of Waitr and Calithera Biosciences, among others
seekingalpha  ·  2023-03-02
Nasdaq to delist shares of Waitr and Calithera Biosciences, among others
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Metacrine, Inc. from The Nasdaq Stock Market
GlobeNewswire  ·  2023-03-01
Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Metacrine, Inc. from The Nasdaq Stock Market

Introduction

Company Name.
Metacrine, Inc.
Affiliated Markets:
PINK
Listing Date:
--
Main Business:
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Issue price:
--